Invion Stock

Invion Revenue

The revenue of Invion (IVX.AX) as of Aug 10, 2026.

Revenue

0.00AUD

Last updated:

In 2026, Invion's sales reached 0.00 AUD, a % difference from the 3.69 M AUD sales recorded in the previous year.

Over the last 18 years Invion grew revenue by 3.0% annually, reaching 3.69 M AUD.

The Invion Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

REVENUE (M AUD)
GROSS MARGIN (%)
Date
REVENUE (M AUD)
GROSS MARGIN (%)
Jan 1, 2018
0.74 base
164.02 base
Jan 1, 2019
3.88 base
31.17 base
Jan 1, 2020
3.48 base
34.80 base
Jan 1, 2021
2.33 base
34.81 base
Jan 1, 2022
3.29 base
29.44 base
Jan 1, 2023
4.10 base
29.48 base
Jan 1, 2024
3.69 base
32.75 base
Jan 1, 2025
0.00 base
0.00 base
YEARREVENUE (M AUD)GROSS MARGIN (%)
2025 --
2024 3.6932.75
2023 4.1029.48
2022 3.2929.44
2021 2.3334.81
2020 3.4834.80
2019 3.8831.17
2018 0.74164.02
2017 --
2016 0.14850.91
2015 0.21572.10
2014 0.30403.33
2013 0.111,100.00
2012 0.32378.13
2011 0.21576.19
2010 0.82147.56
2009 1.3490.30
2008 1.21100.00
2007 1.8266.48
2006 2.1656.02
Access this data via the Eulerpool API

Invion Revenue

Invion Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
737,700.00 AUD
-808,600.00 AUD
-4.87 M AUD
Jan 1, 2019
3.88 M AUD
-2.52 M AUD
-1.06 M AUD
Jan 1, 2020
3.48 M AUD
-1.03 M AUD
-953,900.00 AUD
Jan 1, 2021
2.33 M AUD
-1.57 M AUD
-1.48 M AUD
Jan 1, 2022
3.29 M AUD
-2.32 M AUD
-2.24 M AUD
Jan 1, 2023
4.10 M AUD
-1.61 M AUD
-1.61 M AUD
Jan 1, 2024
3.69 M AUD
-5.39 M AUD
-5.63 M AUD
Jan 1, 2025
0.00 AUD
-8.11 M AUD
-8.81 M AUD

Invion Margins

Invion stock margins

The Invion margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Invion. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Invion.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
29.48 %
-109.61 %
-660.17 %
Jan 1, 2019
29.48 %
-64.85 %
-27.41 %
Jan 1, 2020
29.48 %
-29.52 %
-27.44 %
Jan 1, 2021
34.81 %
-67.48 %
-63.65 %
Jan 1, 2022
29.44 %
-70.52 %
-68.09 %
Jan 1, 2023
29.48 %
-39.34 %
-39.34 %
Jan 1, 2024
29.48 %
-145.84 %
-152.34 %
Jan 1, 2025
29.48 %
- %
- %

Invion Stock analysis

What does Invion do? Invion Ltd is an Australian company specializing in the development of treatment solutions for respiratory and inflammatory diseases. The company was originally founded in 2000 and is headquartered in Perth, Western Australia. It began as a company called CBio that focused on developing technology to prevent blood clot formation. In 2004, it was renamed Invion and shifted its focus to developing treatment solutions for respiratory and inflammatory diseases. Invion has acquired several pharmaceutical companies and has developed an innovative pipeline of products. The company is positioned as a biopharmaceutical company specializing in the discovery and development of treatments based on immunological research for the prevention, diagnosis, and treatment of severe respiratory and inflammatory diseases. It utilizes a combination of proprietary platform technology and internal expertise and collaborates with small and mid-sized pharmaceutical companies. Invion is divided into three main business divisions: antiviral treatment, immunomodulation, and diagnostics. In terms of products, Invion has several in development stages, including INV102 for severe asthma, INV103 for Covid-19, INV104 for lung inflammation, INV027 for COPD, and INV043 for allergic asthma. Overall, Invion aims to improve patient care and diagnosis in the respiratory and inflammatory disease space through innovative technologies. Invion is one of the most popular companies on Eulerpool.

Revenue Details

Understanding Invion's Sales Figures

The sales figures of Invion originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Invion’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Invion's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Invion’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Invion stock

On Eulerpool you can find the complete historical development of The revenue Invion since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's Invion historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Invion

All Key Metrics — Invion